logo

Vivus Inc (VVUS)



Trade VVUS now with
  Date
  Headline
6/2/2020 7:39:59 AM VIVUS Announces Updated Agreement With Icahn Enterprises Holdings L.P.
5/1/2020 8:39:35 AM VIVUS Agrees With IEH Biopharma Granting The Company A 30-Day Grace Period To Restructure Corporate Debt
4/3/2020 8:06:49 AM VitalTech Announces Partnership With VIVUS
2/5/2020 7:35:30 AM VIVUS Gets FDA Approval For Improved Formulation Of PANCREAZE With A 36-Month Shelf Life
1/7/2020 7:34:09 AM VIVUS Announces Publication Of New Study From Toolbox Trial
12/31/2019 7:35:31 AM VIVUS Adopts Stockholder Rights Plan
10/7/2019 7:58:24 AM VIVUS Accepts Marketing Authorization Application For Qsymia In Europe On A Decentralized Basis
8/5/2019 8:01:41 AM VIVUS Announces Approval Of Qsymia In The Republic Of Korea
8/5/2019 7:37:18 AM VIVUS Reports Approval Of Qsymia In The Republic Of Korea
1/14/2019 7:37:11 AM VIVUS : Data Supporting Cardiovascular Safety Of Qsymia Published
9/26/2018 7:34:46 AM VIVUS Regains Compliance With Nasdaq Listing Requirements
9/21/2018 7:31:27 AM VIVUS Supports Cystic Fibrosis Community Thro Sponsorship Of And Participation In Cystic Fibrosis Foundation’s CF Climb
8/6/2018 7:32:06 AM VIVUS Appoints Ken Suh To The Position Of President
7/10/2018 7:33:33 AM VIVUS Announces Positive Results From Phase 1 Clinical Trial Of VI-0106